The Definitive Peptide Research Reference Guide — Compound Review

Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Semaglutide Dosage BPC-157 Dosage Research Guides Joint Pain Weight Loss Longevity Shop Purgo Labs

For Men

Research guide for for men — mechanisms, protocols, and independent analysis from Compound Review.

Why NAD+ Decline Matters for Men

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, DNA repair, and sirtuin activation. In men, NAD+ levels decline approximately 50% between ages 20 and 60, contributing to reduced mitochondrial efficiency, impaired DNA damage response, and declining metabolic rate. NAD+ precursor supplementation (NMN, NR) and direct IV NAD+ administration are studied as strategies to restore cellular NAD+ pools.

NAD+ Dosage by Form

For men seeking systemic NAD+ restoration, IV infusions of 250–1000 mg NAD+ are used in clinical and research settings, typically over 2–4 hours to minimize side effects (flushing, nausea). Oral NMN (250–1000 mg/day) and NR (300–600 mg/day) are more accessible alternatives with emerging human evidence for NAD+ elevation. Subcutaneous NAD+ injection (100–200 mg/day) is used in some research protocols as a middle ground between IV and oral routes.

Evidence Summary for Men

Human evidence for NAD+ precursors includes Phase 1/2 trials confirming NAD+ elevation in blood and muscle tissue. Clinical outcomes — improved insulin sensitivity, muscle function, and cognitive performance — have been demonstrated in small trials. Larger Phase 3 trials are ongoing. NAD+ itself is not a peptide and is not regulated as a drug in most jurisdictions; precursor supplements are widely available.